Drug Trial Radar · NCT06215261
An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD
Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
62
Actual
Start
Apr 4, 2024
Primary completion
Sep 23, 2025
Study completion Sep 23, 2025
Sponsor
- Lead sponsor
- Transcend TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jan 22, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is evaluating the safety and efficacy of methylone in adults with PTSD. The study is conducted in two parts. * Part A is open-label and will enroll up to 15 participants with PTSD * Part B is randomized (1:1:1), single-blind and will enroll up to 45 participants with PTSD Eligible participants will enter a 3-week Treatment Period (Part A) or 4-week Treatment Period (Part B) where they will receive methylone once weekly. Following the Treatment Period, participants will enter a 6-week Follow-up Period (Part A) or 8-week Follow-up Period (Part B).
Conditions
- Post Traumatic Stress Disorder
Interventions
MethyloneDrug
Methylone capsules, given orally, once a week for 3 weeks (Part A) or 4 weeks (Part B)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Clinician-Administered PTSD Scale for the DSM-5 (CAPS-5) Total Severity ScoreTime frame: 9 weeks (Part A) / 12 weeks (Part B)
Locations
12 sites in 3 countries. Site status is shown where the registry gives one.
Segal Trials
Lauderhill, Florida
Accel Research
Maitland, Florida
CNS Healthcare
Orlando, Florida
Uptown Clinical Research
Chicago, Illinois
Sunstone Medical
Rockville, Maryland
Redbird Research LLC
Las Vegas, Nevada
Numinus
Draper, Utah
Seattle NTC
Bellevue, Washington
Swinburne University of Technology
Hawthorn, Victoria, Australia
Ramsay Clinic Albert Road
Melbourne, Victoria, Australia
Monarch Mental Health Group
Melbourne, Victoria, Australia
Clerkenwell Health
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.